\
&
Contact us
\
&
Contact us
Published on | 8 months ago
ProgrammesThe Falling Walls Lab (FWL) Marie Skłodowska-Curie Actions (MSCA) 2025 is accepting submissions that showcase the quality, diversity and passion of the most innovative minds participating in the MSCA.
The FWL competition is an opportunity for MSCA fellows to present their projects and innovative ideas to the scientific community through 3-minute talks. During the talks, the speakers explain how their research helps to break down walls in science and society. This year’s edition will take place on 18 and 19 September 2025 in Lyngby, Denmark, as part of the MSCA conference organised with the Danish Presidency of the Council of the EU (more information on the conference).
This year, MSCA will participate in two competitions organised by the Falling Walls Foundation:
The selected contestants will have the opportunity to take part in a professional coaching session and travel to Denmark to attend the MSCA Presidency Conference. The best projects will also get a chance to take part in the finale 6 to 9 November 2025 in Berlin, where they will follow a prestigious networking programme. The finalists of Falling Walls Venture will further have the chance to attract new investors and funding.
The submission deadline is extended from 18 May 2025 to 1 June 2025 at 12:00 CEST.
The full call and eligibility conditions are available in this MSCA news article. Both the submission form (EU Survey) and submission form on FWL’s website will have to be completed.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
On 28 January 2026, the SECURE project has launched a first round of financial support measures to help small businesses achieve compliance with new cybersecurity requirements for their hardware and software products. This will allow micro, small and medium enterprises (MSMEs) to request co-funding to strengthen the cybersecurity of their hardware... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
